Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
ablation, arterial, Attorney, augment, autotransfusion, California, cardiac, Cardiva, Clara, closure, Commission, cooperating, demonstrated, developmental, distributor, District, electrophysiology, femoral, greater, growing, hand, headquarter, HemoAssay, inorganic, inquiry, interventional, Merger, MVP, penetration, peripheral, prioritize, Santa, Science, SEC, subpoena, Suzhou, temporary, VASCADE, vascular, vessel
Removed:
capacity, CSL, occurred
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view